Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.062 5 days ( -8.18 % )
Last Price HK$20.90 3.98 %
High/ Low HK$19.82 - HK$21.00 14.03%
Chg 7 Days 11.65 % $18.72 HK$20.90
Chg 30 Days 17.28 % $17.82 HK$20.90
Chg 12 mos 0.240 % $20.85 HK$20.90
Trend - 3 mos -30.88 % Width: 56.83 %
Trend - 12 mos -1.34 % Width: 76.47 %
Pred. range - 3 mos HK$9.21 - HK$14.45 -55.93 % - -30.88 %
Pred. range - 12 mos HK$15.47 - HK$27.29 -26.00 % - 30.60 %
Short MA avg 3 mos Buy Apr 22, 2024 - 15 days
Long MA avg 3 mos Buy May 06, 2024 - 6 days
Short/Long MA avg 3 mos Buy May 08, 2024 - 4 days
Short MA avg 12 mos Buy Apr 26, 2024 - 11 days
Long MA avg 12 mos Sell Mar 04, 2024 - 47 days
Short/Long MA avg 12 mos Sell Feb 06, 2024 - 64 days
Pivot Short Buy Apr 19, 2024 - 16 days
Bollinger Buy May 07, 2024 - 5 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Ascentage Pharma Group International

Ascentage Pharma Group International Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation, as well as for patients with tyrosine kinase inhibitor resistant chronic phase chronic myeloid leukemia. It als... 6855.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT